ALECXIH JAMES enters TRISALUS LIFE SCIENCES, INC. with 94.75K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 8/14/2023ACC: 0001209191-23-045710
Officer· President, Device Technology
Since Aug 2023
94.75K
Baseline shares
100% direct
94.75K
Direct ownership
1 position
94.75K
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned94.75K
Total
94.75K direct94.75K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 94.75K | Direct |
| Total | 94.75K | 94.75K direct |
Derivative Holdings1
Employee Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
94.75K
Shares owned
N/A
Exercise price
10.30
Expiration
—
Exercise window
—
Total
Underlying
94.75K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock | 10.30 | — | — | 94.75K | N/A |
| Total | 94.75K | 0.00 | ||||